Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi
(Eur J Rheumatol 2017; 4: 288-290) DOI: 10.5152/eurjrheum.2017.16112